Pierre Antoine Gourraud

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses
    Pierre Antoine Gourraud
    Department of Neurology, University of California, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Immunogenetics 62:729-40. 2010
  2. ncbi Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis
    Pierre Antoine Gourraud
    Department of Neurology, UCSF School of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Invest Dermatol 132:2171-5. 2012
  3. ncbi Standard methods for the management of immunogenetic data
    Pierre Antoine Gourraud
    Department of Neurology, University of California, San Francisco, CA, USA
    Methods Mol Biol 882:197-213. 2012
  4. ncbi The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines
    Pierre Antoine Gourraud
    Department of Neurology, University of California San Francisco School of Medicine, San Francisco, California, USA
    Stem Cells 30:180-6. 2012
  5. ncbi When is the absence of evidence, evidence of absence? Use of equivalence-based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C allelic association in multiple sclerosis
    Pierre Antoine Gourraud
    Department of Neurology, School of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0435, USA
    Genet Epidemiol 35:568-71. 2011
  6. ncbi Refining the association of MHC with multiple sclerosis in African Americans
    Joseph P McElroy
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    Hum Mol Genet 19:3080-8. 2010
  7. ncbi Aggregation of multiple sclerosis genetic risk variants in multiple and single case families
    Pierre Antoine Gourraud
    Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA, USA
    Ann Neurol 69:65-74. 2011
  8. ncbi Analytical methods for disease association studies with immunogenetic data
    Jill A Hollenbach
    Center for Genetics, Children s Hospital and Research Center Oakland, Oakland, CA, USA
    Methods Mol Biol 882:245-66. 2012
  9. ncbi The genetics of multiple sclerosis: an up-to-date review
    Pierre Antoine Gourraud
    Department of Neurology, University of California San Francisco, San Francisco, CA 94143 0435, USA
    Immunol Rev 248:87-103. 2012
  10. ncbi Analytical methods for immunogenetic population data
    Steven J Mack
    Center for Genetics, Children s Hospital and Research Center Oakland, Oakland, CA, USA
    Methods Mol Biol 882:215-44. 2012

Collaborators

Detail Information

Publications18

  1. ncbi Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses
    Pierre Antoine Gourraud
    Department of Neurology, University of California, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Immunogenetics 62:729-40. 2010
    ..The present study provides a rationale for analyzing associations of KIR polymorphisms by taking into account the complex LD structure of the KIR region...
  2. ncbi Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis
    Pierre Antoine Gourraud
    Department of Neurology, UCSF School of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Invest Dermatol 132:2171-5. 2012
    ..The ICC is preferable to the commonly used statistics (r and ρ) for assessing the inter-rater agreement reliability of asymmetrically distributed scores such as the PASI...
  3. ncbi Standard methods for the management of immunogenetic data
    Pierre Antoine Gourraud
    Department of Neurology, University of California, San Francisco, CA, USA
    Methods Mol Biol 882:197-213. 2012
    ....
  4. ncbi The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines
    Pierre Antoine Gourraud
    Department of Neurology, University of California San Francisco School of Medicine, San Francisco, California, USA
    Stem Cells 30:180-6. 2012
    ..The constitution of a haplobank of iPSC lines is achievable through a large-scale concerted worldwide collaboration...
  5. ncbi When is the absence of evidence, evidence of absence? Use of equivalence-based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C allelic association in multiple sclerosis
    Pierre Antoine Gourraud
    Department of Neurology, School of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0435, USA
    Genet Epidemiol 35:568-71. 2011
    ..The data gathered for KIF1B in MS also underscore the need for very large sample sizes with the appropriate equivalence statistical methods in order to exclude reported false-positive results...
  6. ncbi Refining the association of MHC with multiple sclerosis in African Americans
    Joseph P McElroy
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    Hum Mol Genet 19:3080-8. 2010
    ....
  7. ncbi Aggregation of multiple sclerosis genetic risk variants in multiple and single case families
    Pierre Antoine Gourraud
    Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA, USA
    Ann Neurol 69:65-74. 2011
    ..We aimed at investigating the aggregation of genetic MS risk markers in individuals by comparing multiple- and single-case families...
  8. ncbi Analytical methods for disease association studies with immunogenetic data
    Jill A Hollenbach
    Center for Genetics, Children s Hospital and Research Center Oakland, Oakland, CA, USA
    Methods Mol Biol 882:245-66. 2012
    ..case-control vs. family data) as well as the specific research hypotheses being tested. This paper describes the various study and analysis categories used for such analyses, including the advantages and limitations of such techniques...
  9. ncbi The genetics of multiple sclerosis: an up-to-date review
    Pierre Antoine Gourraud
    Department of Neurology, University of California San Francisco, San Francisco, CA 94143 0435, USA
    Immunol Rev 248:87-103. 2012
    ....
  10. ncbi Analytical methods for immunogenetic population data
    Steven J Mack
    Center for Genetics, Children s Hospital and Research Center Oakland, Oakland, CA, USA
    Methods Mol Biol 882:215-44. 2012
    ..The extent to which the data and analyses are appropriate to each other should be determined before any analyses are performed...
  11. ncbi A genome-wide association study of brain lesion distribution in multiple sclerosis
    Pierre Antoine Gourraud
    Department of Neurology, School of Medicine, University of California, San Francisco, 675 Nelson Rising Lane, Suite 215, San Francisco, CA 94158, USA
    Brain 136:1012-24. 2013
    ....
  12. ncbi Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes
    Walter D Funk
    BioTime, Inc, Alameda, CA, USA
    Stem Cell Res 8:154-64. 2012
    ..The combined application of cytogenetic and molecular technologies provides a detailed understanding of genomic and sequence profiles of GMP produced ES lines for potential use as therapeutic agents...
  13. ncbi Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset
    Pouya Khankhanian
    Department of Neurology, University of California, San Francisco, CA 94143 0435, USA
    BMC Genomics 11:626. 2010
    ..Attempts at replication of these genetic results in human studies, however, have reached conflicting conclusions...
  14. ncbi Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
    Ellen M Mowry
    Multiple Sclerosis Center, Department of Neurology, University of California at San Francisco, San Francisco, CA, USA
    Ann Neurol 72:234-40. 2012
    ..We sought to determine whether vitamin D status is associated with developing new T2 lesions or contrast-enhancing lesions on brain magnetic resonance imaging (MRI) in relapsing multiple sclerosis (MS)...
  15. ncbi A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32
    Wendy Cozen
    Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Blood 119:469-75. 2012
    ..In a separate analysis, the DRB1*0701 allele was associated with a decreased risk of NSHL (OR = 0.5, 95% confidence interval = 0.4, 0.7). These data support the importance of the HLA class II region in NSHL etiology...
  16. ncbi B cell exchange across the blood-brain barrier in multiple sclerosis
    H Christian von Büdingen
    Department of Neurology, UCSF, San Francisco, California 94158, USA
    J Clin Invest 122:4533-43. 2012
    ..These data also provide a powerful approach to identify and monitor B cells in the PB that correspond to clonally amplified populations in the CNS in MS and other inflammatory states...
  17. ncbi An admission bioclinical score to predict 1-year outcomes in patients undergoing aneurysm coiling
    Vincent Degos
    Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA 94110, USA
    Stroke 43:1253-9. 2012
    ..Our goal was to develop, compare, and validate a predictive score for 1-year outcomes in patients with coiled subarachnoid hemorrhage...
  18. ncbi A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement
    J A Hollenbach
    Center for Genetics, Children s Hospital and Research Center Oakland, Oakland, CA, USA
    Tissue Antigens 78:333-44. 2011
    ..As with the STREGA guidelines, the intent behind STREIS is not to dictate the design of immunogenomic studies, but to ensure consistent and transparent reporting of research, facilitating the synthesis of HLA and KIR data across studies...